GPBAR1 and Insulin resistance: Similar to TGR5, the studies with FXR knockout mice and FXR agonists support the notion that FXR regulates BA metabolism and metabolic profiles to prevent metabolic conditions such as insulin resistance and atherosclerosis [114].